Suspected exceedance of acceptable levels of NDMA and NDEA impurities in the active substance Valsartanum from the supplier Zhejiang Tianyu Pharmaceuticals; subsequent tests did not confirm limit exceedances. Potential effects: possible carcinogenic effects with long-term exposure.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Patients may continue to use Valzek 160 mg as prescribed; if in doubt, they should consult their doctor or pharmacist.
Initially, all batches of Valzek 160 mg containing active substance from Zhejiang Tianyu Pharmaceuticals were suspended from the market (decision No. 49/WS/2018), and subsequently, after demonstrating...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related